Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 383Breast Neoplasms 366Colorectal Neoplasms 238Stomach Neoplasms 222Carcinoma, Hepatocellular 155Lung Neoplasms 123Neoplasms 120Pancreatic Neoplasms 110Prostatic Neoplasms 101Neoplasm Metastasis 98Rectal Neoplasms 96Recurrence 94Ovarian Neoplasms 91Nasopharyngeal Carcinoma 88Esophageal Neoplasms 84Esophageal Squamous Cell Carcinoma 83Lymphoma, Large B-Cell, Diffuse 80Melanoma 77Lymphoma 72Small Cell Lung Carcinoma 71Uterine Cervical Neoplasms 70Sarcoma 70Leukemia, Myeloid, Acute 70Brain Neoplasms 69Squamous Cell Carcinoma of Head and Neck 67Head and Neck Neoplasms 67Multiple Myeloma 66Carcinoma, Renal Cell 64Triple Negative Breast Neoplasms 62Colonic Neoplasms 53

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Unknown × Pseudomonas Infections × Clear all
NCT05975151 2023-09-21

Efficacy and Safety of Pseudomonas Aeruginosa for Intermediate and High-risk Non-muscle Invasive Bladder Cancer

Qilu Hospital of Shandong University

Phase 2 Unknown
63 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Pseudomonas Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡